Drugmaker Johnson & Johnson has issued a voluntary recall of 57,000 bottles of its Topamax epilepsy and migraine drug due to complaints of an “uncharacteristic odor” associated with the tablets.
Read more from the original source:
Johnson & Johnson Recalls Topamax Due to Odor